GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-20 12:50 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Asia, South Korea, Law & Courts, Crime & Justice, Asia Pacific
--------------------------------------------------------------------
Snippet:
SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in a phase 1b clinical trial.
--------------------------------------------------------------------